18.10.2017 / 13.30 - 19.30 Uhr / MDC.C
Dechema visits Berlin-Buch: Trading in cells - Lab cultures, patients, and the promise of applications
Cell therapies carry high dreams and expectations with them, based on a simple idea: to optimize the body’s own resources to eradicate diseases. Some are already available on the market, for instance to treat articular cartilage defect and to treat damaged corneas with limbal stem cells. But most of them are still in an early stage of development or in clinical trials – to treat cancer, heart failure, diabetes or prevent transplant rejection. The market size of the successful ones is expected to grow rapidly in the near future.
This year, the symposium “DECHEMA visits Berlin-Buch” will highlight the latest developments in the field of cell therapies.
Two international key notes, Steven A. Goldman from the University of Rochester, US, and Michele De Luca from the University of Modena, Italy, will present their work on stem cells for the therapy of neurodegenerative diseases and skin regeneration respectively. Further experts from industry and academia will present their current projects and challenges.
A poster session in the afternoon break and a get-together in the evening will provide plenty of time for networking.
The meeting is free of charge. You can register online on the DECHEMA website.
Call for Poster
You are cordially invited to present your project with a poster. We have only space for 30 posters! Please send your name and the title of your poster to Annett Krause (email@example.com) as soon as possible.
13:00 Registration Open
Chair: Daniel Besser, German Stem Cell Network (GSCN)
13:30 Welcome, Christina Quensel, CEO of BBB Management GmbH Campus Berlin-Buch
13:45 Steven A. Goldman, Center for Translational Neuromedicine, University of Rochester Medical Center/Center for Basic and Translational Neuroscience, University of Copenhagen, Faculty of Health and Medical Sciences
Stem cell-based treatment and modeling of neuropsychiatric disease
14:15 Kai Pinkernell, Medigene AG
Transformation of a biotech company to a developer of innovative cell-based therapeutics
14:30 Elisa Kieback, Max Delbrück Center for Molecular Medicine
A clinical Phase I trial of MAGE-A1-specific T cell receptor gene therapy
14:45 Anna Nowak, Charité / German Rheumatism Research Centre Berlin (DRFZ)
Purification of stable human Treg for improved generation of genetically engineered CAR-Treg
15:00 Dirk Gustavus, Zellwerk
Expansion of Immunocells for Therapy in a Perfusion Bioreactor System
15:15 Break with Poster session
16:45 Michele De Luca, University of Modena, Centre for Regenerative Medicine
Combined ex vivo cell and gene therapy of epidermolysis bullosa by transgenic epidermal stem cells
17:15 Giulietta Roël, co.don AG
Defining the manufacturing design of an autologous cell-based therapy for cartilage repair to improve its efficacy
17:30 Petra Reinke, Berlin-Brandenburg Center for Regenerative Therapies BCRT
BECAT - a new research cluster for cell and gene therapies
17:45 Christian Regenbrecht, cpo - cellular phenomics & oncology GmbH
Goodbye flat biology - the use of 3D cell cultures as pre-clinical models
The DECHEMA Satellite Meeting is organized by Berlin Partner for Business and Technology GmbH, the Campus Berlin-Buch and supported by DECHEMA e.V.
Venue: Max Delbrück Communications Center, C83, Axon 2
Max Delbrück Communications Center, Robert-Rössle-Str. 10, 13125 Berlin-Buch